This invention relates to compounds of Formula I
that inhibit the secretion of apolipoprotein B, to pharmaceutical compositions comprising the compounds, and to methods of treating and/or preventing atherosclerosis, obesity, diabetes, hyperlipidernia, hyperliproproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, pancreatitis, myocardial infarction, stroke, restenosis, or Syndrome X. This invention also relates to methods of reducing the secretion of apolipoprotein B and/or inhibiting microsomal triglyceride transfer protein.
本发明涉及可抑制
载脂蛋白 B 分泌的式 I
本发明涉及抑制
载脂蛋白 B 分泌的式 I 化合物,涉及包含该化合物的药物组合物,还涉及治疗和/或预防动脉粥样硬化、肥胖症、糖尿病、高脂血症、高脂蛋白血症、高
胆固醇血症、高
甘油三酯血症、低脑脂蛋白血症、胰腺炎、心肌梗塞、中风、再狭窄或 X 综合征的方法。本发明还涉及减少
载脂蛋白 B 分泌和/或抑制微粒体
甘油三酯转移蛋白的方法。